Skip to main content
Top
Published in: Cancer & Metabolism 1/2016

Open Access 01-12-2016 | Review

Warburg effect(s)—a biographical sketch of Otto Warburg and his impacts on tumor metabolism

Author: Angela M. Otto

Published in: Cancer & Metabolism | Issue 1/2016

Login to get access

Abstract

Virtually everyone working in cancer research is familiar with the “Warburg effect”, i.e., anaerobic glycolysis in the presence of oxygen in tumor cells. However, few people nowadays are aware of what lead Otto Warburg to the discovery of this observation and how his other scientific contributions are seminal to our present knowledge of metabolic and energetic processes in cells. Since science is a human endeavor, and a scientist is imbedded in a network of social and academic contacts, it is worth taking a glimpse into the biography of Otto Warburg to illustrate some of these influences and the historical landmarks in his life. His creative and innovative thinking and his experimental virtuosity set the framework for his scientific achievements, which were pioneering not only for cancer research. Here, I shall allude to the prestigious family background in imperial Germany; his relationships to Einstein, Meyerhof, Krebs, and other Nobel and notable scientists; his innovative technical developments and their applications in the advancement of biomedical sciences, including the manometer, tissue slicing, and cell cultivation. The latter were experimental prerequisites for the first metabolic measurements with tumor cells in the 1920s. In the 1930s–1940s, he improved spectrophotometry for chemical analysis and developed the optical tests for measuring activities of glycolytic enzymes. Warburg’s reputation brought him invitations to the USA and contacts with the Rockefeller Foundation; he received the Nobel Prize in 1931. World politics and world wars heavily affected Warburg’s scientific survival in Berlin. But, after his second postwar recovery, Warburg’s drive for unraveling the energetic processes of life, both in plants and in tumor cells, continued until his death in 1970. The legacy of Otto Warburg is not only the Warburg effect, but also the identification of the “respiratory ferment” and hydrogen-transferring cofactors and the isolation of glycolytic enzymes. His hypothesis of respiratory damage being the cause of cancer remains to be a provocative scientific issue, along with its implications for cancer treatment and prevention. Warburg is therefore still stimulating our thinking, as documented in a soaring increase in publications citing his name in the context of tumor metabolism.
Literature
2.
go back to reference Racker E. Bioenergetics and the problem of tumor growth: an understanding of the mechanism of the generation and control of biological energy may shed light on the problem of tumor growth. Am Sci. 1972;60(1):56–63. doi:10.2307/27842946.PubMed Racker E. Bioenergetics and the problem of tumor growth: an understanding of the mechanism of the generation and control of biological energy may shed light on the problem of tumor growth. Am Sci. 1972;60(1):56–63. doi:10.​2307/​27842946.PubMed
3.
go back to reference Krebs H, Schmid R. Otto Warburg Zellphysiologe - Biochemiker - Mediziner 1983-1970. Grosse Naturforscher. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 1979. Krebs H, Schmid R. Otto Warburg Zellphysiologe - Biochemiker - Mediziner 1983-1970. Grosse Naturforscher. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 1979.
4.
go back to reference Werner P. Otto Warburg - Von der Zellphysiologie zur Krebsforschung. Berlin: Verlag Neues Leben; 1988. Werner P. Otto Warburg - Von der Zellphysiologie zur Krebsforschung. Berlin: Verlag Neues Leben; 1988.
6.
go back to reference Minami S. Versuche an überlebenden Carcinomgewebe [Atmung und Glykolyse]. Biochem Zeitschr. 1923;142:334–50. Minami S. Versuche an überlebenden Carcinomgewebe [Atmung und Glykolyse]. Biochem Zeitschr. 1923;142:334–50.
7.
go back to reference Burk D, Sprince H, Spangler JM, Kabat EA, Furth J, Claude A. The metabolism of chicken tumors. J Natl Canc Inst. 1941;2(3):201–40. Burk D, Sprince H, Spangler JM, Kabat EA, Furth J, Claude A. The metabolism of chicken tumors. J Natl Canc Inst. 1941;2(3):201–40.
10.
go back to reference Warburg O, Posener K, Negelein E. Über den Stoffwechsel der Carcinomzelle. Biochem Zeitschr. 1924;152:309–44. Warburg O, Posener K, Negelein E. Über den Stoffwechsel der Carcinomzelle. Biochem Zeitschr. 1924;152:309–44.
13.
go back to reference Cori CF, Cori GT. The carbohydrate metabolism of tumors: II. changes in the sugar, lactic acid, and CO2-combining power of blood passing through a tumor. J Biol Biochem. 1925;65(2):397–405. Cori CF, Cori GT. The carbohydrate metabolism of tumors: II. changes in the sugar, lactic acid, and CO2-combining power of blood passing through a tumor. J Biol Biochem. 1925;65(2):397–405.
14.
go back to reference Warburg O. Notiz uber den Stoffwechsel der Tumoren. Biochem Zeitschr. 1930;228(1/3):257–8. Warburg O. Notiz uber den Stoffwechsel der Tumoren. Biochem Zeitschr. 1930;228(1/3):257–8.
17.
go back to reference Warburg O. The oxygen-transferring ferment of respiration. Nobel Lectures. 1931. Warburg O. The oxygen-transferring ferment of respiration. Nobel Lectures. 1931.
18.
go back to reference Hofmann E. Enzyme - die Katalysatoren der lebendigen Substanz. Berichte der Akademie der Wissenschaften. 1985;3/N:25–40. Hofmann E. Enzyme - die Katalysatoren der lebendigen Substanz. Berichte der Akademie der Wissenschaften. 1985;3/N:25–40.
19.
go back to reference Warburg O, Gawehn K, Geissler AW. Über die Entstehung des Krebsstoffwechsels in der Gewebekultur. Zeitschr Naturforsch B. 1958;13(2):61–3. Warburg O, Gawehn K, Geissler AW. Über die Entstehung des Krebsstoffwechsels in der Gewebekultur. Zeitschr Naturforsch B. 1958;13(2):61–3.
21.
go back to reference Burk D, Schade AL. On respiratory impairment in cancer cells. Science. 1956;124(3215):270–2.PubMed Burk D, Schade AL. On respiratory impairment in cancer cells. Science. 1956;124(3215):270–2.PubMed
22.
go back to reference Warburg O. On respiratory impairment in cancer cells. Science. 1956;124(3215):269–70.PubMed Warburg O. On respiratory impairment in cancer cells. Science. 1956;124(3215):269–70.PubMed
23.
25.
go back to reference Warburg O, Geissler AW, Lorenz S. Entstehung von Krebsstoffwechsel durch Vitamin-B1-Mangel (Thiaminmangel). Zeitschr Naturforsch B. 1970;b 25(3):332–3. Warburg O, Geissler AW, Lorenz S. Entstehung von Krebsstoffwechsel durch Vitamin-B1-Mangel (Thiaminmangel). Zeitschr Naturforsch B. 1970;b 25(3):332–3.
28.
go back to reference Bhat P, Darunte L, Kareenhalli V, Dandekar J, Kumar A. Can metabolic plasticity be a cause for cancer? Warburg-Waddington legacy revisited. Clin Epigenetics. 2011;2(2):113–22.CrossRefPubMedPubMedCentral Bhat P, Darunte L, Kareenhalli V, Dandekar J, Kumar A. Can metabolic plasticity be a cause for cancer? Warburg-Waddington legacy revisited. Clin Epigenetics. 2011;2(2):113–22.CrossRefPubMedPubMedCentral
29.
go back to reference Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325–37.CrossRefPubMed Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325–37.CrossRefPubMed
30.
go back to reference Alfarouk KO, Verduzco D, Rauch C, Muddathir AK, Bashir AHH, Elhassan GO, et al. Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question. Oncoscience. 2014;1(12):777–802.CrossRefPubMedPubMedCentral Alfarouk KO, Verduzco D, Rauch C, Muddathir AK, Bashir AHH, Elhassan GO, et al. Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question. Oncoscience. 2014;1(12):777–802.CrossRefPubMedPubMedCentral
Metadata
Title
Warburg effect(s)—a biographical sketch of Otto Warburg and his impacts on tumor metabolism
Author
Angela M. Otto
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Cancer & Metabolism / Issue 1/2016
Electronic ISSN: 2049-3002
DOI
https://doi.org/10.1186/s40170-016-0145-9

Other articles of this Issue 1/2016

Cancer & Metabolism 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine